ADVISORY-PDF of Special Report on Roche

by reuters | Thomson Reuters Foundation
Thursday, 16 September 2010 16:05 GMT

The Swiss drugmaker thinks of itself as a biotech star. But a series of problems with existing drugs and upcoming products has slowed its momentum. Is CEO Severin Schwan on the right track?

For pdf:

Our Standards: The Thomson Reuters Trust Principles.